PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma - OncLive
PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma OncLive
Hodgkin Lymphoma News
Jeff Sharman, MD, on Advances in Non-Hodgkin Lymphoma Treatment - targetedonc.com
Jeff Sharman, MD, on Advances in Non-Hodgkin Lymphoma Treatment targetedonc.com
Evaluation of Lymphadenopathy in Urgent Care: A Case of Hodgkin Lymphoma - Cureus
Evaluation of Lymphadenopathy in Urgent Care: A Case of Hodgkin Lymphoma Cureus
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds - The ASCO Post
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds The ASCO Post
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - mdanderson.org
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult mdanderson.org
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
British rap star Sway dead at 44. ‘Little Derek’ hitmaker was diagnosed with Hodgkin lymphoma in 2010. Lea - The Economic Times
British rap star Sway dead at 44. ‘Little Derek’ hitmaker was diagnosed with Hodgkin lymphoma in 2010. Lea The Economic Times
Saratoga Springs cancer survivor heads to Washington, D.C. to urge more trial access - WRGB
Saratoga Springs cancer survivor heads to Washington, D.C. to urge more trial access WRGB
Post-Treatment Fertility in Hodgkin Lymphoma - hematologyadvisor.com
Post-Treatment Fertility in Hodgkin Lymphoma hematologyadvisor.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference health.com
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma - CancerNetwork
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma CancerNetwork
Understanding Hodgkin lymphoma cell origins could yield better diagnostics - Cornell Chronicle
Understanding Hodgkin lymphoma cell origins could yield better diagnostics Cornell Chronicle
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma - clemsontigers.com
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma clemsontigers.com
HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma - Medscape
HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma Medscape
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma - Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma Nature
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma - CancerNetwork
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma CancerNetwork
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life - mdanderson.org
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life mdanderson.org
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL - The ASCO Post
Mosunetuzumab With Response-Adapted Therapy in Previously Untreated NHL The ASCO Post
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal - Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal Nature
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Frontiers
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” Frontiers
Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma - CancerNetwork
Overcoming PD-1 Resistance in Relapsed/Refractory Hodgkin Lymphoma CancerNetwork
London rapper Sway Dasafo dies age 44 as KSI leads tributes to 'true legend' - London Evening Standard
London rapper Sway Dasafo dies age 44 as KSI leads tributes to 'true legend' London Evening Standard
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore - Hartford HealthCare
7 Signs of Non-Hodgkin Lymphoma You Shouldn’t Ignore Hartford HealthCare
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? - Clinical Trials Arena
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? Clinical Trials Arena
Coexistence of Mycosis Fungoides and Hodgkin Lymphoma in a Pediatric Patient: A Report of a Rare Case - Cureus
Coexistence of Mycosis Fungoides and Hodgkin Lymphoma in a Pediatric Patient: A Report of a Rare Case Cureus
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - Medical Xpress
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult Medical Xpress
Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma - CancerNetwork
Favezelimab Combo Boosts PFS vs Chemo in PD-1–Refractory Hodgkin Lymphoma CancerNetwork
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma - CancerNetwork
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma CancerNetwork
A teen found "a sense of control" as she fought cancer. Then, it came back: "I knew it was cancer again." - CBS News
A teen found "a sense of control" as she fought cancer. Then, it came back: "I knew it was cancer again." CBS News
Role of consolidative radiotherapy in preventing relapses and subsequent salvage ASCT in early-stage classic Hodgkin lymphoma - Nature
Role of consolidative radiotherapy in preventing relapses and subsequent salvage ASCT in early-stage classic Hodgkin lymphoma Nature
Acute Disseminated Encephalomyelitis Following Nivolumab Therapy for Hodgkin Lymphoma: A Case Report and Literature Review - Cureus
Acute Disseminated Encephalomyelitis Following Nivolumab Therapy for Hodgkin Lymphoma: A Case Report and Literature Review Cureus
Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound - Ovid
Primary pancreatic non-Hodgkin lymphoma (with... : Endoscopic Ultrasound Ovid
Four-Drug Regimen Induces High Complete Response Rate in Early-Stage Classical Hodgkin Lymphoma - The ASCO Post
Four-Drug Regimen Induces High Complete Response Rate in Early-Stage Classical Hodgkin Lymphoma The ASCO Post
EHA2026 | Congress coverage: Hodgkin lymphoma and T-cell lymphoma - Lymphoma Hub
EHA2026 | Congress coverage: Hodgkin lymphoma and T-cell lymphoma Lymphoma Hub
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma - CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma CancerNetwork
The guitarist was first diagnosed with Hodgkin lymphoma in 2013. - facebook.com
The guitarist was first diagnosed with Hodgkin lymphoma in 2013. facebook.com
Study reveals promising new therapy for non-Hodgkin lymphoma - Medical Xpress
Study reveals promising new therapy for non-Hodgkin lymphoma Medical Xpress
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study - Nature
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study Nature
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma - mdanderson.org
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma mdanderson.org